{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T22:33:18Z","timestamp":1774045998443,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-40468-9","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:46:30Z","timestamp":1771397190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of daily aerobic cycling exercise on cannabis withdrawal: An inpatient randomised controlled trial"],"prefix":"10.1038","volume":"16","author":[{"given":"Llewellyn","family":"Mills","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieron","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"McCartney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridin","family":"Murnion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathon C.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S.","family":"Haber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Arkell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisha","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain S.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Lintzeris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"40468_CR1","unstructured":"UNODC. World Drug Report 2023. United nations office on drugs and crime. (2023)."},{"key":"40468_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106479","author":"J Leung","year":"2020","unstructured":"Leung, J., Chan, G. C. K., Hides, L. & Hall, W. D. What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis. Addict. Behav. https:\/\/doi.org\/10.1016\/j.addbeh.2020.106479 (2020).","journal-title":"Addict. Behav."},{"key":"40468_CR3","unstructured":"WHO. ICD-10 international statistical classification of diseases and related health problems. 10th rev., 2nd ed. ed. International statistical classification of diseases and related health problems. World Health Organization. (2005)."},{"key":"40468_CR4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association DSMTF","year":"2013","unstructured":"American Psychiatric Association DSMTF, American Psychiatric A. Diagnostic and statistical manual of mental disorders: DSM-5 (American Psychiatric Association, 2013)."},{"issue":"4","key":"40468_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2370","volume":"3","author":"A Bahji","year":"2020","unstructured":"Bahji, A., Stephenson, C., Tyo, R., Hawken, E. R. & Seitz, D. P. Prevalence of cannabis withdrawal symptoms among people with regular or dependent use of cannabinoids: a systematic review and meta-analysis. JAMA Netw. Open 3(4), e202370-e202370 (2020).","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"40468_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jsat.2008.01.002","volume":"35","author":"AJ Budney","year":"2008","unstructured":"Budney, A. J., Vandrey, R. G., Hughes, J. R., Thostenson, J. D. & Bursac, Z. Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. J. Subst. Abuse Treat. 35(4), 362\u2013368 (2008).","journal-title":"J. Subst. Abuse Treat."},{"issue":"3","key":"40468_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.biopsych.2012.07.028","volume":"73","author":"M Haney","year":"2013","unstructured":"Haney, M. et al. Predictors of marijuana relapse in the human laboratory: Robust impact of tobacco cigarette smoking status. Biol. Psychiatr. 73(3), 242\u2013248. https:\/\/doi.org\/10.1016\/j.biopsych.2012.07.028 (2013).","journal-title":"Biol. Psychiatr."},{"issue":"9","key":"40468_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044864","volume":"7","author":"DJ Allsop","year":"2012","unstructured":"Allsop, D. J. et al. Quantifying the clinical significance of cannabis withdrawal. PLoS One 7(9), e44864 (2012).","journal-title":"PLoS One"},{"issue":"1","key":"40468_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/npp.2017.212","volume":"43","author":"CA Brezing","year":"2017","unstructured":"Brezing, C. A. & Levin, F. R. The current state of pharmacological treatments for cannabis use disorder and withdrawal. Neuropsychopharmacology 43(1), 173\u2013194. https:\/\/doi.org\/10.1038\/npp.2017.212 (2017).","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"40468_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1037\/1064-1297.6.4.419","volume":"6","author":"AJ Budney","year":"1998","unstructured":"Budney, A. J., Radonovich, K. J., Higgins, S. T. & Wong, C. J. Adults seeking treatment for marijuana dependence: a comparison with cocaine-dependent treatment seekers. Exp. Clin. Psychopharmacol. 6(4), 419 (1998).","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"2","key":"40468_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/16066359.2015.1073719","volume":"24","author":"R Chatters","year":"2016","unstructured":"Chatters, R. et al. Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review. Addictn. Res. Theor. 24(2), 93\u2013110. https:\/\/doi.org\/10.3109\/16066359.2015.1073719 (2016).","journal-title":"Addictn. Res. Theor."},{"issue":"2","key":"40468_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/09540260902782745","volume":"21","author":"J Copeland","year":"2009","unstructured":"Copeland, J. & Swift, W. Cannabis use disorder: Epidemiology and management. Int. Rev. Psychiatr. 21(2), 96\u2013103 (2009).","journal-title":"Int. Rev. Psychiatr."},{"issue":"2","key":"40468_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.psc.2012.03.003","volume":"35","author":"I Danovitch","year":"2012","unstructured":"Danovitch, I. & Gorelick, D. A. State of the art treatments for cannabis dependence. Psychiatr. Clin. North Am. 35(2), 309\u2013326 (2012).","journal-title":"Psychiatr. Clin. North Am."},{"key":"40468_CR14","doi-asserted-by":"crossref","unstructured":"Gates PJ, Sabioni P, Copeland J, Le Foll B, Gowing L. Psychosocial interventions for cannabis use disorder. The Cochrane Library. (2016).","DOI":"10.1002\/14651858.CD005336.pub4"},{"issue":"6","key":"40468_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.7326\/M19-1105","volume":"172","author":"KK Kondo","year":"2020","unstructured":"Kondo, K. K. et al. Pharmacotherapy for the treatment of cannabis use disorder: a systematic review. Ann. Intern. Med. 172(6), 398\u2013412 (2020).","journal-title":"Ann. Intern. Med."},{"key":"40468_CR16","doi-asserted-by":"crossref","unstructured":"Lintzeris N, Sunjic S, Demirkol A, et al. Management of withdrawal from alcohol and other drugs. 1-201 (2019).","DOI":"10.57022\/mjjp9930"},{"issue":"10","key":"40468_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110728","volume":"9","author":"D Wang","year":"2014","unstructured":"Wang, D., Wang, Y., Wang, Y., Li, R. & Zhou, C. Impact of physical exercise on substance use disorders: a meta-analysis. PLoS One 9(10), e110728-e110728. https:\/\/doi.org\/10.1371\/journal.pone.0110728 (2014).","journal-title":"PLoS One"},{"key":"40468_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1126777","volume":"14","author":"H Li","year":"2023","unstructured":"Li, H., Su, W., Cai, J., Zhao, L. & Li, Y. Effects of exercise of different intensities on withdrawal symptoms among people with substance use disorder: a systematic review and meta-analysis. Front. Physiol. 14, 1126777. https:\/\/doi.org\/10.3389\/fphys.2023.1126777 (2023).","journal-title":"Front. Physiol."},{"key":"40468_CR19","doi-asserted-by":"crossref","unstructured":"Lintzeris N, Sunjic S, Demirkol A, et al. Management of withdrawal from alcohol and other drugs: an Evidence Check. https:\/\/www.saxinstitute.org.au\/wp-content\/uploads\/20.08_Evidence-Check_Management-of-withdrawal-from-alcohol-and-other-drugs.pdf (2019).","DOI":"10.57022\/mjjp9930"},{"issue":"2","key":"40468_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1037\/pha0000301","volume":"28","author":"MA Prince","year":"2020","unstructured":"Prince, M. A., Collins, R. L., Wilson, S. D. & Vincent, P. C. A preliminary test of a brief intervention to lessen young adults\u2019 cannabis use: Episode-level smartphone data highlights the role of protective behavioral strategies and exercise. Exp. Clin. Psychopharmacol. 28(2), 150\u2013156. https:\/\/doi.org\/10.1037\/pha0000301 (2020).","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"3","key":"40468_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017465","volume":"6","author":"MS Buchowski","year":"2011","unstructured":"Buchowski, M. S. et al. Aerobic exercise training reduces cannabis craving and use in non-treatment seeking cannabis-dependent adults. PLoS One 6(3), e17465. https:\/\/doi.org\/10.1371\/journal.pone.0017465 (2011).","journal-title":"PLoS One"},{"issue":"5","key":"40468_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1521-0391.2014.12135.x","volume":"23","author":"JG Irons","year":"2014","unstructured":"Irons, J. G., Babson, K. A., Bergeria, C. L. & Bonn-Miller, M. O. Physical activity and cannabis cessation. Am. J. Addict. 23(5), 485\u201392. https:\/\/doi.org\/10.1111\/j.1521-0391.2014.12135.x (2014).","journal-title":"Am. J. Addict."},{"key":"40468_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/616935","volume":"2014","author":"G Flemmen","year":"2014","unstructured":"Flemmen, G., Unhjem, R. & Wang, E. High-intensity interval training in patients with substance use disorder. BioMed Res. Int. 2014, 616935. https:\/\/doi.org\/10.1155\/2014\/616935 (2014).","journal-title":"BioMed Res. Int."},{"issue":"1","key":"40468_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1748-1716.1991.tb09205.x","volume":"143","author":"R Bahr","year":"1991","unstructured":"Bahr, R., H\u00d8Stmark, A. T., Newsholme, E. A., Gr\u00d8Nner\u00d8D, O. & Sejersted, O. M. Effect of exercise on recovery changes in plasma levels of FFA, glycerol, glucose and catecholamines. Acta Physiol. Scand. 143(1), 105\u2013115. https:\/\/doi.org\/10.1111\/j.1748-1716.1991.tb09205.x (1991).","journal-title":"Acta Physiol. Scand."},{"issue":"5","key":"40468_CR25","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1111\/j.1476-5381.2009.00399.x","volume":"158","author":"N Gunasekaran","year":"2009","unstructured":"Gunasekaran, N. et al. Reintoxication: The release of fat\u2010stored \u03949\u2010tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure. Br. J. Pharmacol. 158(5), 1330\u20131337. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00399.x (2009).","journal-title":"Br. J. Pharmacol."},{"issue":"20","key":"40468_CR26","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1007\/s00213-014-3532-3","volume":"231","author":"A Wong","year":"2014","unstructured":"Wong, A. et al. Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: An examination of behavioural consequences. Psychopharmacology 231(20), 3987\u20133996. https:\/\/doi.org\/10.1007\/s00213-014-3532-3 (2014).","journal-title":"Psychopharmacology"},{"issue":"5","key":"40468_CR27","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1111\/j.1476-5381.2009.00399.x","volume":"158","author":"N Gunasekaran","year":"2009","unstructured":"Gunasekaran, N. et al. Reintoxication: The release of fat\u2010stored \u03949\u2010tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure. Br. J. Pharmacol. 158(5), 1330\u20131337 (2009).","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"40468_CR28","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.drugalcdep.2013.07.031","volume":"133","author":"A Wong","year":"2013","unstructured":"Wong, A. et al. Exercise increases plasma THC concentrations in regular cannabis users. Drug Alcohol Depend. 133(2), 763\u2013767 (2013).","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"40468_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/bcpt.12235","volume":"115","author":"AA Westin","year":"2014","unstructured":"Westin, A. A., Mj\u00f8nes, G., Burchardt, O., Fuskev\u00e5g, O. M. & Sl\u00f8rdal, L. Can physical exercise or food deprivation cause release of fat\u2010stored cannabinoids?. Basic Clin. Pharmacol. Toxicol. 115(5), 467\u2013471. https:\/\/doi.org\/10.1111\/bcpt.12235 (2014).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"3","key":"40468_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10865-015-9617-6","volume":"38","author":"MA Kredlow","year":"2015","unstructured":"Kredlow, M. A., Capozzoli, M. C., Hearon, B. A., Calkins, A. W. & Otto, M. W. The effects of physical activity on sleep: A meta-analytic review. J. Behav. Med. 38(3), 427\u2013449 (2015).","journal-title":"J. Behav. Med."},{"key":"40468_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cpr.2018.11.002","volume":"68","author":"H Lowe","year":"2019","unstructured":"Lowe, H. et al. Does exercise improve sleep for adults with insomnia? a systematic review with quality appraisal. Clin. Psychol. Rev. 68, 1\u201312 (2019).","journal-title":"Clin. Psychol. Rev."},{"issue":"4","key":"40468_CR32","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s12160-014-9685-9","volume":"49","author":"GL Stonerock","year":"2015","unstructured":"Stonerock, G. L., Hoffman, B. M., Smith, P. J. & Blumenthal, J. A. Exercise as treatment for anxiety: systematic review and analysis. Ann. Behav. Med. 49(4), 542\u2013556 (2015).","journal-title":"Ann. Behav. Med."},{"key":"40468_CR33","first-page":"1003","volume":"2011","author":"A Cipriani","year":"2011","unstructured":"Cipriani, A., Barbui, C., Butler, R., Hatcher, S. & Geddes, J. Depression in adults: drug and physical treatments. BMJ clin. Evid. 2011, 1003 (2011).","journal-title":"BMJ clin. Evid."},{"issue":"6","key":"40468_CR34","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/10826084.2022.2052098","volume":"57","author":"R Dowla","year":"2022","unstructured":"Dowla, R. et al. The effectiveness of exercise as an adjunct intervention to improve quality of life and mood in substance use disorder: A systematic review. Subst. Use Misuse 57(6), 911\u2013928. https:\/\/doi.org\/10.1080\/10826084.2022.2052098 (2022).","journal-title":"Subst. Use Misuse"},{"key":"40468_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mhpa.2017.06.002","volume":"13","author":"DJ Allsop","year":"2017","unstructured":"Allsop, D. J. et al. Randomised controlled trial (RCT) of daily aerobic exercise for inpatient cannabis withdrawal: a study protocol. Ment. Health Phys. Act. 13, 57\u201367 (2017).","journal-title":"Ment. Health Phys. Act."},{"issue":"3","key":"40468_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.13211","volume":"30","author":"D McCartney","year":"2021","unstructured":"McCartney, D. et al. The effect of daily aerobic cycling exercise on sleep quality during inpatient cannabis withdrawal: a randomised controlled trial. J. Sleep Res. 30(3), e13211. https:\/\/doi.org\/10.1111\/jsr.13211 (2021).","journal-title":"J. Sleep Res."},{"key":"40468_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mhpa.2017.06.002","volume":"13","author":"DJ Allsop","year":"2017","unstructured":"Allsop, D. J. et al. Randomised controlled trial (RCT) of daily aerobic exercise for inpatient cannabis withdrawal: a study protocol. Ment. Health Phys. Act. 13, 57\u201367. https:\/\/doi.org\/10.1016\/j.mhpa.2017.06.002 (2017).","journal-title":"Ment. Health Phys. Act."},{"key":"40468_CR38","unstructured":"World Health Organization. International statistical classification of diseases and related health, 10th revision. WHO (2010)."},{"issue":"1","key":"40468_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1037\/1064-1297.10.1.47","volume":"10","author":"EG Singleton","year":"2002","unstructured":"Singleton, E. G., Trotman, A. J. M., Zavahir, M., Taylor, R. C. & Heishman, S. J. Determination of the reliability and validity of the marijuana craving questionnaire using imagery scripts. Exp. Clin. Psychopharmacol. 10(1), 47\u201353. https:\/\/doi.org\/10.1037\/1064-1297.10.1.47 (2002).","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"40468_CR40","unstructured":"American College of Sports Medicine ib, Liguori G, Feito Y, Fountaine C, Roy B. ACSM\u2019s guidelines for exercise testing and prescription. Eighth edition. ed. American College of Sports Medicine\u2019s guidelines for exercise testing and prescription. Wolters Kluwer. (2022)."},{"issue":"1-2","key":"40468_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.drugalcdep.2011.06.003","volume":"119","author":"DJ Allsop","year":"2011","unstructured":"Allsop, D. J., Norberg, M. M., Copeland, J., Fu, S. & Budney, A. J. The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress. Drug Alcohol Depend. 119(1\u20132), 123\u2013129 (2011).","journal-title":"Drug Alcohol Depend."},{"issue":"1-3","key":"40468_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.drugalcdep.2008.12.010","volume":"102","author":"SJ Heishman","year":"2009","unstructured":"Heishman, S. J. et al. Reliability and validity of a short form of the marijuana craving questionnaire. Drug Alcohol Depend. 102(1\u20133), 35\u201340. https:\/\/doi.org\/10.1016\/j.drugalcdep.2008.12.010 (2009).","journal-title":"Drug Alcohol Depend."},{"key":"40468_CR43","unstructured":"Oehlert GW. A first course in design and analysis of experiments. (2010)."},{"key":"40468_CR44","unstructured":"R: A language and environment for statistical computing. R Foundation for Statistical Computing. https:\/\/www.r-project.org\/ (2016)."},{"key":"40468_CR45","doi-asserted-by":"crossref","unstructured":"Wickham H. Tidyverse: easily install and load\u2019tidyverse\u2019packages. R package version 121 1(1), (2017).","DOI":"10.32614\/CRAN.package.tidyverse"},{"key":"40468_CR46","unstructured":"nlme: linear and nonlinear mixed effects models. Version 3.1-128. http:\/\/CRAN.R-project.org\/package=nlme (2016)"},{"key":"40468_CR47","unstructured":"Lenth RV. emmeans: estimated marginal means, aka least-squares means. R package Version 1-5-3. (2020)."},{"issue":"1","key":"40468_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0305-0491(98)00025-X","volume":"120","author":"GA Brooks","year":"1998","unstructured":"Brooks, G. A. Mammalian fuel utilization during sustained exercise. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 120(1), 89\u2013107 (1998).","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"key":"40468_CR49","doi-asserted-by":"publisher","first-page":"1126777","DOI":"10.3389\/fphys.2023.1126777","volume":"14","author":"H Li","year":"2023","unstructured":"Li, H., Su, W., Cai, J., Zhao, L. & Li, Y. Effects of exercise of different intensities on withdrawal symptoms among people with substance use disorder: a systematic review and meta-analysis. Front. physiol.. 14, 1126777. https:\/\/doi.org\/10.3389\/fphys.2023.1126777 (2023).","journal-title":"Front. physiol.."},{"issue":"3","key":"40468_CR50","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/jamapsychiatry.2013.3947","volume":"71","author":"DJ Allsop","year":"2014","unstructured":"Allsop, D. J. et al. Nabiximols as an agonist replacement therapy during Cannabis withdrawal: a randomized clinical trial. JAMA Psychiatr. 71(3), 281\u2013291. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.3947 (2014).","journal-title":"JAMA Psychiatr."},{"issue":"24","key":"40468_CR51","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1007\/s00213-014-3611-5","volume":"231","author":"J Johnston","year":"2014","unstructured":"Johnston, J. et al. Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting. Psychopharmacology 231(24), 4623\u20134636. https:\/\/doi.org\/10.1007\/s00213-014-3611-5 (2014).","journal-title":"Psychopharmacology"},{"issue":"3","key":"40468_CR52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2217\/fnl-2016-0035","volume":"12","author":"I Pokorski","year":"2017","unstructured":"Pokorski, I. et al. Cannabidiol in the management of in-patient cannabis withdrawal: clinical case series. Future Neurol. 12(3), 133\u2013140 (2017).","journal-title":"Future Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40468-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40468-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40468-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T21:01:43Z","timestamp":1774040503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40468-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40468"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40468-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nicholas Lintzeris and Paul Haber have received funding for research unrelated to this study from Indivior and Camurus. ISM is the Academic Director of the Lambert Initiative for Cannabinoid Therapeutics. He has served as an expert witness in various medicolegal cases involving cannabis and has received consulting fees from Medical Cannabis Industry Australia (MCIA), Althea, and Janssen. He has acted as an advisor\/consultant to Kinoxis Therapeutics, Psylo, and Emyria and has had salary support from the NHMRC and from Lambert Initiative for Cannabinoid Therapeutics. He is an inventor on patents WO2017004674, WO2018107216, WO2020102857 and AU2022240104 licensed to Kinoxis Therapeutics, involving the use of novel small molecules (non-cannabinoid) to treat addictions, social deficits, opioid withdrawal and aggression. He is an inventor on issued patents WO2019227167 and WO2019071302 which relate to cannabinoid therapeutics. Jonathon Arnold has served as an expert witness in various medicolegal cases involving cannabis and has received consulting fees from Medical Cannabis Industry Australia (MCIA) and Haleon (consumer healthcare subsidiary of Glaxo Smith-Kline).\u202f He reports research grants from the Australian National Health and Medical Research Council (NHMRC) and from Lambert\u202fInitiative for Cannabinoid Therapeutics. He is an inventor on patents WO2019227167 and WO2019071302 issued, which relate to cannabinoid therapeutics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9527"}}